Pubblicazioni

Malattie dell'Apparato Digerente, Endoscopia e Trapianto di Fegato
  1. BARONE M, IANNONE A, BRUNETTI ND, SEBASTIANI F, CECERE O, BERARDI E, ANTONICA G, DI LEO A. Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance. Scand J Gastroenterol. 2015 May;50(5):560-6.
  2. LOSURDO G, PRINCIPI M, DI LEO A, IERARDI E. Letter: Helicobacter-negative gastritis--a distinct condition? Aliment Pharmacol Ther. 2015 Mar;41(6):597-8.
  3. PISELLI P, BURRA P, LAURO A, BACCARANI U, ETTORRE GM, VIZZINI GB, RENDINA M, ROSSI M, TISONE G, ZAMBONI F, BORTOLUZZI I, PINNA AD, RISALITI A, GALATIOTO L, VENNARECCI G, DI LEO A, NUDO F, SFORZA D, FANTOLA G, CIMAGLIA C, VERDIROSI D, VIRDONE S, SERRAINO D; ITALIAN TRANSPLANT AND CANCER COHORT STUDY. Head and neck and esophageal cancers after liver transplant: results from a multicenter cohort study. Italy, 1997-2010. Transpl Int. 2015 Jul;28(7):841-8.
  4. LICINIO R, PRINCIPI M, LOSURDO G, IERARDI E, DI LEO A. Letter: portal vein obstruction--which subset of patients could benefit the most? Aliment Pharmacol Ther. 2015 May;41(9):909.
  5. FACCIORUSSO A, LICINIO R, CARR BI, DI LEO A, BARONE M. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):993-1003.
  6. IERARDI E, LOSURDO G, PISCITELLI D, GIORGIO F, SORRENTINO C, PRINCIPI M, MONTENEGRO L, AMORUSO A, DI LEO A. Seronegative celiac disease: where is the specific setting? Gastroenterol Hepatol Bed Bench. 2015 Spring;8(2):110-6.
  7. IERARDI E, GIORGIO F, LOSURDO G, SORRENTINO C, PRINCIPI M, DI LEO A. Detection of helicobacter pylori dna sequences in gastric biopsy samples to refine the diagnosis and therapy. J Med Microbiol. 2015 May 1.
  8. FACCIORUSSO A, MUSCATIELLO N, DI LEO A, BARONE M. Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial? Am J Gastroenterol. 2015 May;110(5):770-1.
  9. LICINIO R, LOSURDO G, IERARDI E, DI LEO A, PRINCIPI M. Letter: tumour necrosis factor alpha blocker switching--a not so simple pharmacokinetic. Aliment Pharmacol Ther. 2015 Jun;41(12):1302.
  10. FACCIORUSSO A, DEL PRETE V, CRUCINIO N, MUSCATIELLO N, CARR BI, DI LEO A, BARONE M. Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients. J Gastroenterol Hepatol. 2015 May 14.
  11. BARONE M, VIGGIANI MT, AMORUSO A, SCHIRALDI S, ZITO A, DEVITO F, CORTESE F, GESUALDO M, BRUNETTI N, DI LEO A, SCICCHITANO P, CICCONE MM. Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection. Gastroenterol Res Pract. 2015;2015:682174.
  12. PRINCIPI M, LOSURDO G, LA FORTEZZA RF, LOPOLITO P, LOVERO R, GRILLO S, BRINGIOTTI R, IERARDI E, DI LEO A. Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation. J Gastrointestin Liver Dis. 2015 Jun;24(2):165-70.
  13. LOSURDO G, LEANDRO G, PRINCIPI M, GIORGIO F, MONTENEGRO L, SORRENTINO C, IERARDI E, DI LEO A. Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'. Int J Clin Pract. 2015 Jul 2
  14. LOSURDO G, PISCITELLI D, GIANGASPERO A, PRINCIPI M, BUFFELLI F, GIORGIO F, MONTENEGRO L, SORRENTINO C, AMORUSO A, IERARDI E, DI LEO A. Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up. World J Gastroenterol. 2015 Jun 28;21(24):7545-52.
  15. LICINIO R, FACCIORUSSO A, CASTELLANETA NM, DI LEO A. Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases? Am J Gastroenterol. 2015 Jul;110(7):1086.
  16. BARONE M, SCAVO MP, LICINIO R, PIOMBINO M, DE TULLIO N, MALLAMACI R, DI LEO A. Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation. Stem Cells Int. 2015;2015:354193.
  17. BARONE M, DELLA VALLE N, ROSANIA R, FACCIORUSSO A, TROTTA A, CANTATORE FP, FALCO S, PIGNATIELLO S, VIGGIANI MT, AMORUSO A, DE FILIPPIS R, DI LEO A, FRANCAVILLA R. A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects. Eur J Clin Nutr. 2015 Jul 15.
  18. PRINCIPI M, MONTENEGRO L, LOSURDO G, ZITO A, DEVITO F, BULZIS G, CARBONARA R, IERARDI E, DI LEO A, CICCONE MM. Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase. Scand J Gastroenterol. 2015 Jul 25:1-3.
  19. FACCIORUSSO A, LICINIO R, MUSCATIELLO N, DI LEO A, BARONE M. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol. 2015 Aug 8;7(16):2009-19.
  20. Ierardi E, Sorrentino C, Principi M, Giorgio F, Losurdo G, Di Leo A. Intestinal microbial metabolism of phosphatidylcholine: a novel insight in the cardiovascular risk scenario. Hepatobiliary Surg Nutr. 2015 Aug;4(4):289-92.
  21. Facciorusso A, Licinio R, Di Leo A. Machine Learning Methods in Gastroenterology. Gastroenterology. 2015 Oct;149(4):1128-9.
  22. Giorgio F, Principi M, Losurdo G, Piscitelli D, Iannone A, Barone M, Amoruso A, Ierardi E, Di Leo A. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg? Nutrients. 2015 Sep 8;7(9):7486-504.
  23. Ierardi E, Losurdo G, Sorrentino C, Giorgio F, Rossi G, Marinaro A, Romagno KR, Di Leo A, Principi M. Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey. Scand J Gastroenterol. 2016 Mar;51(3):277-80.
  24. Ierardi E, Amoruso A, Giorgio F, Principi M, Losurdo G, Piscitelli D, Buffelli F, Fiore MG, Mongelli A, Castellaneta NM, Giangaspero A, De Francesco V, Montenegro L, Di Leo A. Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages. Saudi J Gastroenterol. 2015 Nov-Dec;21(6):379-85.
  25. Losurdo G, Iannone A, Contaldo A, Ierardi E, Di Leo A, Principi M. Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis. J Gastrointestin Liver Dis. 2015 Dec;24(4):499-505.
  26. Gesualdo M, Scicchitano P, Carbonara S, Ricci G, Principi M, Ierardi E, Di Leo A, Cortese F, Ciccone MM. The association between cardiac and gastrointestinal disorders: causal or casual link? J Cardiovasc Med (Hagerstown). 2016 May;17(5):330-8.
  27. Scardapane A, Ambrosi A, Salinaro E, Mancini ME, Principi M, Di Leo A, Lorusso F, Stabile Ianora AA, Angelelli G. Assessment of Disease Activity in Small Bowel Crohn's Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score. Gastroenterol Res Pract. 2015;2015:159641.
  28. Castellaneta A, Massaro A, Rendina M, D'Errico F, Carparelli S, Rizzi SF, Thomson AW, Di Leo A. Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence. Transplant Res. 2016 Jan 20;5:1.
  29. Losurdo G, Iannone A, Principi M, Barone M, Ranaldo N, Ierardi E, Di Leo A. Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission. Eur J Intern Med. 2016 May;30:88-93.
  30. Losurdo G, Iannone A, Giorgio F, Ierardi E, Di Leo A, Principi M. A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of "Geographic Weight". Saudi J Gastroenterol. 2016 Jan-Feb;22(1):77-8.
  31. Iannone A, Losurdo G, Pricci M, Girardi B, Massaro A, Principi M, Barone M, Ierardi E, Di Leo A. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis. J Gastrointest Cancer. 2016 Jun;47(2):143-51.
  32. Losurdo G, Iannone A, Giorgio F, Principi M, Di Leo A, Ierardi E. Letter: could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? Aliment Pharmacol Ther. 2016 Apr;43(7):844-5
  33. Losurdo G, Principi M, Girardi B, Pricci M, Barone M, Ierardi E, Di Leo A. HISTAMINE AND HISTAMINERGIC RECEPTORS IN COLORECTAL CANCER: FROM BASIC SCIENCE TO EVIDENCE-BASED MEDICINE. Anticancer Agents Med Chem. 2016 Mar 21. [Epub ahead of print]
  34. Di Leo A, Nesi G, Principi M, Piscitelli D, Girardi B, Pricci M, Losurdo G, Iannone A, Ierardi E, Tonelli F. Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors? World J Gastroenterol. 2016 Mar 21;22(11):3202-11.
  35. Principi M, Cassano N, Contaldo A, Iannone A, Losurdo G, Barone M, Mastrolonardo M, Vena GA, Ierardi E, Di Leo A. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol. 2016 May 28;22(20):4802-11.
  36. Losurdo G, Iannone A, Giorgio F, Principi M, Di Leo A, Ierardi E. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens? United European Gastroenterol J. 2016 Jun;4(3):474-5.

37. Papagni S, Rizzi S, Principi M, Albano F, Contaldo A, Iannone A, Losurdo G, Genco E, Lastella P, Ierardi E, DI  Leo A. Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? Minerva Gastroenterol Dietol. 2016 Sep;62(3):272-3

Azioni sul documento

pubblicato il 11/12/2017 — ultima modifica 11/12/2017